Events at the DeWitt Wallace Institute

Apr
03
1:15pm - 2:45pm

“Type and Character” Merve Emre, Ph.D., Wesleyan University

Merve Emre, Ph.D.
May
01
1:15pm - 2:45pm

“Madness and Enterprise: Psychiatry, Economic Reason, and the Emergence of Pathological Value” Nima Bassiri, Ph.D., Duke University

Nima Bassiri, Ph.D.
May
15
1:15pm - 2:45pm

“The Analyst’s Self as Instrument: Asset or Liability or Both?” Elizabeth Lunbeck, Ph.D., Harvard University

Elizabeth Lunbeck, Ph.D., Harvard University
May
17
12:00pm - 1:30pm

Neuromodulation is the use of medications or technology to alter the activity of neurons with the goal of reducing symptoms, improving functioning, and improving quality of life. Over the past year, there have been some changes to the neuromodulation program here at NewYork–Presbyterian and Weill Cornell Medicine. Dr. Dennis Popeo will discuss uses for electroconvulsive therapy beyond mood disorders. Dr. Roy Smetana will discuss ketamine treatment. Dr. Benjamin Zebley will discuss TMS. After the presentations, the three presenters will field questions from the audience about access to these services and other topics of interest regarding neuromodulation.

Learning Objectives

  1. Describe the uses of ketamine, ECT and TMS in patients with other disorders aside from treatment resistant depression.
  2. Explain the risks and benefits of ketamine, ECT and TMS.
  3. Discuss the profile of the patient who would best be treated with ketamine, ECT and TMS.
  4. Describe general mechanism of transcranial magnetic stimulation (TMS) and its effect on the brain.
  5. Describe recent advances in the field, including the use of MRI-guided neuronavigation to identify brain targets.
neuromodulation